Investment bankers are quitting Goldman, Citigroup for biotech riches in Hong Kong

“We are seeing a very good level of interest from quality issuers and we expect a healthy pipeline for the next couple years,” said David Lau, head of Hong Kong investment banking at JPMorgan Chase & …
( read original story …)

---